The compound [6-trimethylphenyl)imidazol-2-ylidene][2-thienylmethylene]ruthenium(II) dichloride is a highly efficient organometallic catalyst widely used in advanced chemical synthesis and pharmaceutical research. Known for its robust stability and exceptional catalytic activity, this ruthenium-based complex plays a crucial role in olefin metathesis and other transition-metal-catalyzed transformations. Shanghai Lizhuo Pharmaceutical Technology Co., Ltd., a leading China manufacturer, supplier, and factory, specializes in producing this high-purity catalyst with stringent quality control to meet diverse industrial demands. Leveraging state-of-the-art technology and extensive experience, Shanghai Lizhuo Pharmaceutical Technology Co., Ltd. ensures reliable supply and competitive pricing, supporting innovations in medicinal chemistry and material science. Customers globally trust their expertise and commitment to excellence, making them a preferred partner for research institutions and pharmaceutical companies alike.